USRE32393F1 - Composition for enhancing the administration of pharmacologically active agents - Google Patents

Composition for enhancing the administration of pharmacologically active agents Download PDF

Info

Publication number
USRE32393F1
USRE32393F1 US60576084A USRE32393F1 US RE32393 F1 USRE32393 F1 US RE32393F1 US 60576084 A US60576084 A US 60576084A US RE32393 F1 USRE32393 F1 US RE32393F1
Authority
US
Grant status
Grant
Patent type
Prior art keywords
enhancing
administration
composition
active agents
pharmacologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
Original Assignee
Kabi Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
USRE32393F1 1967-09-01 1984-08-14 Composition for enhancing the administration of pharmacologically active agents Expired - Lifetime USRE32393F1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE12159/67 1967-09-01
SE1215967 1967-09-01

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US05666264 Division US4073943A (en) 1974-09-11 1976-03-12 Method of enhancing the administration of pharmalogically active agents
US05854404 Reissue US4168308A (en) 1974-09-11 1977-11-23 Composition for enhancing the administration of pharmacologically active agents

Publications (2)

Publication Number Publication Date
USRE32393E USRE32393E (en) 1987-04-07
USRE32393F1 true USRE32393F1 (en) 1990-05-29

Family

ID=20295252

Family Applications (1)

Application Number Title Priority Date Filing Date
USRE32393F1 Expired - Lifetime USRE32393F1 (en) 1967-09-01 1984-08-14 Composition for enhancing the administration of pharmacologically active agents

Country Status (6)

Country Link
US (1) USRE32393F1 (en)
DE (1) DE1792410B2 (en)
DK (1) DK129272C (en)
FR (2) FR1593013A (en)
GB (1) GB1229967A (en)
NL (1) NL6812429A (en)

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973465A (en) * 1986-12-05 1990-11-27 Ire-Celltarg S.A. Microcrystals comprising an active substance having an affinity for phospholipids, and at least one phospholipid, process of preparation
WO1990014837A1 (en) * 1989-05-25 1990-12-13 Chiron Corporation Adjuvant formulation comprising a submicron oil droplet emulsion
US5229422A (en) * 1987-09-07 1993-07-20 Teijin Limited Extemporaneous preparation type kit of a pharmaceutical substance-containing fat emulsion
US5314685A (en) * 1992-05-11 1994-05-24 Agouron Pharmaceuticals, Inc. Anhydrous formulations for administering lipophilic agents
US5560931A (en) * 1995-02-14 1996-10-01 Nawosystems L.L.C. Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
US5635536A (en) * 1994-12-07 1997-06-03 Pharmacia & Upjohn Aktiebolag Emulsion suitable for administering a sphingolipid
US5714520A (en) * 1994-03-22 1998-02-03 Zeneca Limited Propofol compostion containing edetate
US5731355A (en) * 1994-03-22 1998-03-24 Zeneca Limited Pharmaceutical compositions of propofol and edetate
US5851510A (en) * 1994-05-16 1998-12-22 The Board Of Regents Of The University Of Michigan Hepatocyte-selective oil-in-water emulsion
US6221378B1 (en) 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
US20020006442A1 (en) * 1998-08-19 2002-01-17 Rtp Pharma Inc. Injectable aqueous dispersions of propofol
US20030134908A1 (en) * 1994-03-22 2003-07-17 Jones Christopher Buchan Pharmaceutical compositions
US20030180367A1 (en) * 1996-08-22 2003-09-25 Skyepharma Canada, Inc. Microparticles of water-insoluble substances
US20040022819A1 (en) * 1993-10-07 2004-02-05 Takeshi Ikemoto Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
US20060067952A1 (en) * 2004-09-28 2006-03-30 Sd Pharmaceuticals, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
US20060189700A1 (en) * 1994-03-22 2006-08-24 Astrazeneca Uk Limited Pharmaceutical compositions
US20060210622A1 (en) * 1999-09-21 2006-09-21 Skyepharma Canada Inc. Surface modified particulate compositions of biologically active substances
US7255877B2 (en) 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US20070207173A1 (en) * 2006-02-01 2007-09-06 Sd Pharmaceuticals, Inc. Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
US7939106B2 (en) 1998-11-20 2011-05-10 Jagotec Ag Process for preparing a rapidly dispersing solid drug dosage form
US8415329B1 (en) 1998-05-29 2013-04-09 Jagotec Ag Thermoprotected compositions and process for terminal steam sterilization of microparticle preparations

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI811745L (en) * 1980-06-19 1981-12-20 Draco Ab Science pharmaceutical composition of foerfarande Foer framstaellning daerav
JPH042595B2 (en) * 1983-07-05 1992-01-20
DE3339236A1 (en) * 1983-10-28 1985-05-09 Bayer Ag drug preparation
DE3515335C2 (en) * 1985-04-27 1995-01-26 Bayer Ag Pharmaceutical preparation containing dihydropyridines and processes for their preparation
DK159807C (en) * 1989-02-27 1992-06-29 Gunnar Kjems The use of calcium salt containing emulsions for the preparation of oral compositions for the prevention or treatment of calcium deficiency in cattle, in particular by milk fever
DE4107152C2 (en) * 1991-03-06 1994-03-24 Gregor Cevc Preparations for non-invasive administration of antidiabetics
DE4107153A1 (en) * 1991-03-06 1992-09-10 Gregor Cevc Compsns. for application of active agents
US8389551B2 (en) 2006-05-23 2013-03-05 Fermenta Biotech (Uk) Limited Optical enantiomers of phenyramidol and process for chiral synthesis

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3707M (en) * Belge Produits Chimiques Sa Association carnitine lipid emulsions.
CA696819A (en) * 1964-10-27 Kelco Company Edible compositions comprising oil-in-water emulsions
CA659453A (en) * 1963-03-12 Merck And Co. Aqueous solutions of fat soluble vitamins
NL292949A (en) *
DE397396C (en) * 1922-05-09 1924-06-20 Chem Ind Basel A process for preparing durable emulsions of oil-soluble drug
US2055083A (en) * 1932-07-13 1936-09-22 Winthrop Chem Co Inc Pharmaceutical preparation
DE707580C (en) * 1932-07-14 1941-06-26 Ig Farbenindustrie Ag A process for the preparation of therapeutically active substances containing emulsions for injection
DE675966C (en) * 1935-08-25 1939-05-23 Ig Farbenindustrie Ag A process for preparation of clear aqueous solutions of essential oils, camphor, terpenes
DE711777C (en) * 1937-09-21 1941-10-06 Ig Farbenindustrie Ag A process for the preparation of aqueous solutions or emulsions of poorly soluble physiologically active substances in water
US2303236A (en) * 1941-06-10 1942-11-24 Wm S Merrell Co Emulsion
GB744376A (en) * 1952-03-08 1956-02-08 Merck & Co Inc Vitamin emulsions
GB828312A (en) * 1955-06-10 1960-02-17 Donald Berthold Zilversmit Fat composition
US2832721A (en) * 1956-07-23 1958-04-29 Merck & Co Inc Vitamin emulsions
US2988484A (en) * 1956-07-24 1961-06-13 Drew & Co Inc E F Alcohol soluble pharmaceutical compositions
US2853419A (en) * 1956-09-07 1958-09-23 Merck & Co Inc Aqueous fat emulsions and process for preparing the same
US2867565A (en) * 1957-08-12 1959-01-06 Feinstone Wolffe Harry Sulfonamide composition comprising a lipid-aqueous emulsion carrier
US2972565A (en) * 1958-04-04 1961-02-21 Univ Tennessee Res Corp Fat composition
US3085939A (en) * 1959-05-11 1963-04-16 Upjohn Co Oil-in-water emulsion for oral administration, and process for preparation
US3044931A (en) * 1960-01-27 1962-07-17 Geigy Chem Corp Aryloxy acetic acid amides: process for parenteral application
US3096249A (en) * 1960-05-10 1963-07-02 Samuel J Prigal Emulsion composition
GB914894A (en) * 1960-08-12 1963-01-09 Beecham Res Lab Injectable pharmaceutical media
CA725596A (en) * 1960-08-26 1966-01-11 J. Wretlind Arvid Method of preparing intravenously injectable fat emulsions free from side reactions or complications
NL269002A (en) * 1960-09-06
US3089823A (en) * 1961-09-05 1963-05-14 Eastman Kodak Co Aqueous vitamin a oil emulsion
US3216897A (en) * 1961-11-02 1965-11-09 Air Reduction Injectable anesthetic
US3185625A (en) * 1961-11-08 1965-05-25 Brown Ethan Allan Injectionable substances
GB1044623A (en) * 1961-11-16 1966-10-05 Marfleet Refining Company Ltd Improvements in and relating to glyceride esters and/or ethyl fatty esters
GB962209A (en) * 1962-04-19 1964-07-01 Upjohn Co Multi-vitamin compositions containing fluorides
FR3922M (en) * 1963-03-12 1900-01-01
DE1229677B (en) * 1963-10-25 1966-12-01 Nat Res Dev A process for the preparation of injectable, antigens containing emulsions
FR4083M (en) * 1963-10-25 1900-01-01
FR4084M (en) * 1963-11-01
FR4263M (en) * 1964-01-16
US3538216A (en) * 1964-02-20 1970-11-03 Lab De Rech Physiques S A R L Injectable compositions of a drug suspended in an emulsion
GB1035701A (en) * 1964-03-03 1966-07-13 Merck & Co Inc Emulsions suitable for use as adjuvants for immunological agents
US3384545A (en) * 1965-03-09 1968-05-21 Hoffmann La Roche Injectable aqueous emulsions of fat soluble vitamins
US3356575A (en) * 1965-04-13 1967-12-05 Leo Ab Autosterile injectable iodinated oil X-ray contrast medium
GB1081796A (en) * 1965-08-13 1967-08-31 Wright Fleming Inst Of Microbi Improvements in or relating to oily adjuvants for water-in-oil emulsions of antigenic materials
US3995118A (en) * 1975-07-03 1976-11-30 Bell Telephone Laboratories, Incorporated Call processing restoration arrangement for a telephone switching system

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973465A (en) * 1986-12-05 1990-11-27 Ire-Celltarg S.A. Microcrystals comprising an active substance having an affinity for phospholipids, and at least one phospholipid, process of preparation
US5229422A (en) * 1987-09-07 1993-07-20 Teijin Limited Extemporaneous preparation type kit of a pharmaceutical substance-containing fat emulsion
WO1990014837A1 (en) * 1989-05-25 1990-12-13 Chiron Corporation Adjuvant formulation comprising a submicron oil droplet emulsion
US20030147898A1 (en) * 1989-05-25 2003-08-07 Gary Van Nest Adjuvant formulation comprising a submicron oil droplet emulson
US6299884B1 (en) 1989-05-25 2001-10-09 Chiron Corporation Adjuvant formulation comprising a submicron oil droplet emulsion
US20090191226A2 (en) * 1989-05-25 2009-07-30 Novartis Vaccines And Diagnostics, Inc. Adjuvant formulation comprising a submicron oil droplet emulsion
US5314685A (en) * 1992-05-11 1994-05-24 Agouron Pharmaceuticals, Inc. Anhydrous formulations for administering lipophilic agents
US20040022819A1 (en) * 1993-10-07 2004-02-05 Takeshi Ikemoto Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant
US20090098172A1 (en) * 1993-10-07 2009-04-16 Kao Corporation Surfactant, and emulsion cosmetic and liposome each containing the same
US20070292462A1 (en) * 1993-10-07 2007-12-20 Kao Corporation Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant
US5731355A (en) * 1994-03-22 1998-03-24 Zeneca Limited Pharmaceutical compositions of propofol and edetate
US5731356A (en) * 1994-03-22 1998-03-24 Zeneca Limited Pharmaceutical compositions of propofol and edetate
US5908869A (en) * 1994-03-22 1999-06-01 Zeneca Limited Propofol compositions containing edetate
US7125909B2 (en) 1994-03-22 2006-10-24 Astrazeneca Uk Limited Sterile parenteral nutrition compositions
US20030134908A1 (en) * 1994-03-22 2003-07-17 Jones Christopher Buchan Pharmaceutical compositions
US5714520A (en) * 1994-03-22 1998-02-03 Zeneca Limited Propofol compostion containing edetate
US20060189700A1 (en) * 1994-03-22 2006-08-24 Astrazeneca Uk Limited Pharmaceutical compositions
US6126946A (en) * 1994-05-16 2000-10-03 University Of Michigan, The Board Of Regents Hepatocyte-selective oil-in-water emulsion
US5851510A (en) * 1994-05-16 1998-12-22 The Board Of Regents Of The University Of Michigan Hepatocyte-selective oil-in-water emulsion
US5985941A (en) * 1994-05-16 1999-11-16 University Of Michigan Method of making hepatocyte-selective oil-in-water emulsion
US5677341A (en) * 1994-12-07 1997-10-14 Pharmacia & Upjohn Aktiebolag Emulsion suitable for administering a sphingolipid
US5635536A (en) * 1994-12-07 1997-06-03 Pharmacia & Upjohn Aktiebolag Emulsion suitable for administering a sphingolipid
US5560931A (en) * 1995-02-14 1996-10-01 Nawosystems L.L.C. Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
US8206746B2 (en) 1996-08-22 2012-06-26 Jagotec Ag Microparticles of water-insoluble substances
US7255877B2 (en) 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US20030180367A1 (en) * 1996-08-22 2003-09-25 Skyepharma Canada, Inc. Microparticles of water-insoluble substances
US6221378B1 (en) 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
US8415329B1 (en) 1998-05-29 2013-04-09 Jagotec Ag Thermoprotected compositions and process for terminal steam sterilization of microparticle preparations
US20020006442A1 (en) * 1998-08-19 2002-01-17 Rtp Pharma Inc. Injectable aqueous dispersions of propofol
US7097849B2 (en) 1998-08-19 2006-08-29 Jagotec Ag Injectable aqueous dispersions of propofol
US7041705B2 (en) 1998-08-19 2006-05-09 Jagotec Ag Injectable aqueous dispersions of propofol
US7939105B2 (en) 1998-11-20 2011-05-10 Jagotec Ag Process for preparing a rapidly dispersing solid drug dosage form
US7939106B2 (en) 1998-11-20 2011-05-10 Jagotec Ag Process for preparing a rapidly dispersing solid drug dosage form
US20060210622A1 (en) * 1999-09-21 2006-09-21 Skyepharma Canada Inc. Surface modified particulate compositions of biologically active substances
US20060067952A1 (en) * 2004-09-28 2006-03-30 Sd Pharmaceuticals, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
US8557861B2 (en) 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
US20070207173A1 (en) * 2006-02-01 2007-09-06 Sd Pharmaceuticals, Inc. Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
US8470873B2 (en) 2006-02-01 2013-06-25 Mast Therapeutics, Inc. Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof

Also Published As

Publication number Publication date Type
FR8152M (en) 1970-08-17 grant
GB1229967A (en) 1971-04-28 application
NL6812429A (en) 1969-03-04 application
USRE32393E (en) 1987-04-07 grant
DK129272B (en) 1974-09-23 grant
FR1593013A (en) 1970-05-25 grant
DK129272C (en) 1975-02-10 grant
DE1792410B2 (en) 1980-03-13 application
DE1792410A1 (en) 1971-11-11 application

Similar Documents

Publication Publication Date Title
GB1374105A (en) Effervescent compositions
CA930668A (en) Bandage for administering drugs
USRE32393F1 (en) Composition for enhancing the administration of pharmacologically active agents
CA971184A (en) Aliphatic isocyanate compositions
GB1165990A (en) Track-Set
GB1222070A (en) Furniture
JPS52142841A (en) Structure comprising at least two parts
GB1219103A (en) Improvements relating to castors
GB1219102A (en) Improvements relating to castors
CA865552A (en) Towel dispenser
CA798715A (en) Container-dispenser for cosmetics
CA960758A (en) Body organ electrode
CA849369A (en) Tissue pack dispenser for urinals
GB1170483A (en) Liquid-Like Self-Curing Moulding Sand Composition
GB1165257A (en) Fertilisers
GB1184888A (en) Piezoelectric Ceramic Compositions
GB1364563A (en) Interferometer
Mukhopadhyay Kabi Mohitlal
CA931062A (en) Bonding
CA954044A (en) Pharmaceutical composition containing fluoroalkylsilicon compounds
CA945561A (en) Pharmaceutical compositions containing 5-bromoisatin
CA921910A (en) Penicillin preparation
CA935378A (en) Insecticidal and acaricidal compositions
CA943559A (en) N-aryl ureas
CA927397A (en) N-aryl ureas